Hematopoietic Cell Transplantation Fellowship

The Hematopoietic Cell Transplantation (HCT) Program at City of Hope offers a one to two year fellowship for physicians who desire training in clinical hematopoietic cell transplantation and clinical research. This includes autologous HCT for hematologic malignancies and solid tumors, as well as allogeneic and unrelated donor HCT and cord blood transplantation for hematologic malignancies. This fellowship provides extensive clinical training in all aspects of transplantation, including HLA typing, apheresis, cryopreservation, hematopathology and cytogenetics.

 

A Recognized Leader in HCT

City of Hope, a National Cancer Institute-designated comprehensive cancer center, is one of the largest transplant centers in the country, and is a member of the Southwest Oncology Group. City of Hope is supported by research programs in hematopoietic cell transplantation, stem cell biology, gene therapy, hematopathology, immunotherapy, cytogenetics and virology.
 

Program Faculty

  • Andrew Artz, M.D., M.S., Clinical Professor, Division of Leukemia
  • Monzr Al Malki, M.D., Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Elizabeth Budde, M.D., Ph.D., Associate Professor, Division of Lymphoma
  • Alexey Danilov, M.D., Ph.D., Professor, Division of Lymphoma, and Associate Director, Toni Stephenson Lymphoma Center
  • Alex Herrera, M.D., Assistant Professor, Division of Lymphoma, and Co-Director, Lymphoma Fellowship Program
  • Matthew Mei, M.D., Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, Director, HCT/Cellular Therapy Fellowship Program, and Co-Director, Lymphoma Fellowship Program
  • Ryotaro Nakamura, M.D., Professor, Division of Leukemia, Director, Center for Stem Cell Tarnsplantation
  • Nitya Nathwani, M.D., Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Leslie Popplewell, M.D., Associate Clinical Professor and Chief, Division of Lymphoma
  • Vinod Pullarkat, M.D., Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • F. Marc Stewart, M.D., Clinical Professor and Vice Chair, Department of Hematology & Hematopoietic Cell Transplantation  
  • Jasmine Zain, M.D., Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, and Director, T Cell Lymphoma Program
 

Current Fellows

  • Amanda Blackman. D.O. (July 2021 to June 2022)
 

Application Process

Currently taking applications for the 2022 to 2023 fellowship year.  Decision to be made in September, and program will start in July.
 
Qualified applicants should send their CV, personal statement and three letters of recommendation to:
 
Monique Aguilar
Hem/HCT Program Coordinator
 
*We cannot accept candidates on J1 visas*

 

Eligibility

Candidates should be eligible for California licensure. All applicants must be board certified in internal medicine, and board certified or board eligible in hematology/oncology.
 

Salary

Salary is commensurate with experience.